Immune thrombocytopenic purpura.
ITP is a hemorrhagic disorder in which thrombocytopenia is associated with increased peripheral destruction of platelets. It is a syndrome of different diseases, all of which have in common shortened platelet survival owing to the presence of an antiplatelet antibody. Most cases are secondary to an identifiable etiologic agent.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000906:Antibodies; D001327:Autoimmune Diseases / Q000150:complications; D001792:Blood Platelets / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007518:Isoantibodies / Q000096:biosynthesis; D008297:Male; D010976:Platelet Count; D011696:Purpura, Thrombocytopenic / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D011802:Quinidine / Q000009:adverse effects; D011803:Quinine / Q000009:adverse effects; D013156:Splenectomy; D065227:Transfusion Reaction
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D007518:Isoantibodies; D011803:Quinine; D011802:Quinidine